Search Results - Timothy C. Thompson

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    DNA Damage Response Inhibitor and Anti-PD-L1 Therapy for Prostate Cancer: Development of Predictive Biomarkers by Chuandong Geng, Timothy C. Thompson

    Published in Engineering (2022-05-01)
    Get full text
    Article


  2. 2

    Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer by Timothy C. Thompson, Likun Li

    Published in Molecular & Cellular Oncology (2017-07-01)
    Get full text
    Article


  3. 3

    Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit by Paul G Corn, Timothy C Thompson

    Published in Cancer Management and Research (2010-05-01)
    Get full text
    Article


  4. 4

    Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer by Nobuyuki Yanagisawa, Takefumi Satoh, Ken-ichi Tabata, Hideyasu Tsumura, Yasutomo Nasu, Masami Watanabe, Timothy C. Thompson, Isao Okayasu, Yoshiki Murakumo, Shiro Baba, Masatsugu Iwamura

    Published in Asian Journal of Urology (2021-07-01)
    Get full text
    Article


  5. 5

    Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients by Junfeng Xu, Wen-Shin Chang, Chia-Wen Tsai, Da-Tian Bau, Yifan Xu, John W. Davis, Timothy C. Thompson, Christopher J. Logothetis, Jian Gu

    Published in EBioMedicine (2020-02-01)
    Get full text
    Article


  6. 6

    Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma by Yan Liu, Xiaojie Tan, Wenbin Liu, Xi Chen, Xiaomei Hou, Dan Shen, Yibo Ding, Jianhua Yin, Ling Wang, Hongwei Zhang, Yongwei Yu, Jianguo Hou, Timothy C. Thompson, Guangwen Cao

    Published in Chinese Journal of Cancer (2018-01-01)
    Get full text
    Article


  7. 7

    Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling by Styliani Karanika, Theodoros Karantanos, Likun Li, Jianxiang Wang, Sanghee Park, Guang Yang, Xuemei Zuo, Jian H. Song, Sankar N. Maity, Ganiraju C. Manyam, Bradley Broom, Ana M. Aparicio, Gary E. Gallick, Patricia Troncoso, Paul G. Corn, Nora Navone, Wei Zhang, Shuhua Li, Timothy C. Thompson

    Published in Cell Reports (2017-02-01)
    Get full text
    Article


  8. 8

    Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance by Justin R. Gregg, Lisa Newcomb, Ranran Wu, Jennifer Dennison, John W. Davis, Curtis Pettaway, Louis Pisters, John F. Ward, Brian F. Chapin, Lisly Chéry, Ahmet Urkmez, Andrew M. Fang, Noel Higgason, Patricia Troncoso, Carrie R. Daniel, Christopher Logothetis, Timothy C. Thompson, Andrew W. Hahn, Menghan Liu, Yingye Zheng, Dan W. Lin, Samir Hanash, Ehsan Irajizad, Johannes Fahrmann

    Published in Biomarker Research (2024-11-01)
    Get full text
    Article


  9. 9

    Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers by Elavarasan Subramani, Patrick G. Pilié, Rebecca Slack-Tidwell, Paul V. Viscuse, Xianghong Kuang, Thirukumaran Kandasamy, Dominik Awad, Jenny J. Han, Licai Huang, Christine B. Peterson, Amado J. Zurita, Sumit K. Subudhi, Paul G. Corn, Rama Soundararajan, Peter Shepherd, Badrajee Piyarathna, Vasanta Putluri, Nagireddy Putluri, Arun Sreekumar, Yuzhuo Wang, Amina Zoubeidi, Iqbal Mahmud, Sara A. Martinez, Lin Tan, Philip L. Lorenzi, Sreyashi Basu, Sonali Jindal, Padmanee Sharma, Christopher J. Logothetis, Timothy C. Thompson, Daniel E. Frigo, Ana M. Aparicio

    Published in iScience (2026-06-01)
    Get full text
    Article


Search Tools: